Vivera Pharmaceuticals Names Dr. Stephen J. McColgan Chief Medical Officer

09:15 EDT 2 May 2019 | Businesswire
This article has expired, however you can still download the PDF.
Vivera Pharmaceuticals, Inc., a pharmaceutical company focused on non-addictive pain management, today announced the appointment of Stephen J. McColgan, M.D., MBA, as its Chief Medical Officer. Dr. McColgan was o...

Other Sources for this Article

Investor Relations and Canadian Media Inquiries:
Patrick Piette, CFA for Vivera Pharmaceuticals, Inc.

U.S. Media Inquiries:
Brenda Patterson for Vivera Pharmaceuticals, Inc.


More From BioPortfolio on "Vivera Pharmaceuticals Names Dr. Stephen J. McColgan Chief Medical Officer"

Quick Search

Relevant Topics

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...

Surgical treatments
Surgery is a technology consisting of a physical intervention on tissues. All forms of surgery are considered invasive procedures; so-called "noninvasive surgery" usually refers to an excision that does not penetrate the structure being exci...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...